{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T16:30:29Z","timestamp":1784133029722,"version":"3.55.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2012,12,27]],"date-time":"2012-12-27T00:00:00Z","timestamp":1356566400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Med Oncol"],"published-print":{"date-parts":[[2013,3]]},"DOI":"10.1007\/s12032-012-0348-z","type":"journal-article","created":{"date-parts":[[2012,12,26]],"date-time":"2012-12-26T11:40:42Z","timestamp":1356522042000},"source":"Crossref","is-referenced-by-count":24,"title":["Analysis of the clinico-hematological relevance of the breakpoint location within M-BCR in chronic myeloid leukemia"],"prefix":"10.1007","volume":"30","author":[{"given":"Ayda","family":"Bennour","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ines","family":"Ouahchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bechir","family":"Achour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monia","family":"Zaier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yosra Ben","family":"Youssef","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abderrahim","family":"Khelif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Saad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Halima","family":"Sennana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,12,27]]},"reference":[{"key":"348_CR1","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/243290a0","volume":"243","author":"JD Rowley","year":"1973","unstructured":"Rowley JD. A new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining. Nature. 1973;243:290\u20133.","journal-title":"Nature"},{"key":"348_CR2","doi-asserted-by":"crossref","first-page":"187","DOI":"10.3109\/10428199209067600","volume":"21","author":"MCH L\u00e9glise","year":"1996","unstructured":"L\u00e9glise MCH, Pluchon-Rivi\u00e8re E, Calvez JF G Le, Berthou CH, Autrand C, Luc Senseb\u00e8 DB, Balcon D, Le Roux AM. Molecular diagnosis and follow-up in myeloproliferative syndromes and acute leukemias: correlation between expression of fusion transcripts and disease progression in chronic myeloid leukemia. Leuk Lymphoma. 1996;21:187\u201399.","journal-title":"Leuk Lymphoma"},{"key":"348_CR3","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1182\/blood.V76.3.489.489","volume":"76","author":"W Crist","year":"1990","unstructured":"Crist W, Carrol A, Shuster J, Jackson J, Head D, Borowitz M, Behm F, Link M, Steuber P, Ragab A, et al. Philadelphia chromosome-positive childhood acute lymphoblastic leukemia: clinical and cytogenetic characteristics and treatment outcome: a Pediatric Oncology Group (POG) study. Blood. 1990;76:489\u201394.","journal-title":"Blood"},{"key":"348_CR4","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/0092-8674(84)90077-1","volume":"36","author":"J Groffen","year":"1984","unstructured":"Groffen J, Stephenson JR, Heisterkamp N, de Klein A, Bartram CR, Grosveld G. Philadelphia chromosomal breakpoints are clustered within a limited region, bcr, on chromosome 22. Cell. 1984;36:93\u20139.","journal-title":"Cell"},{"key":"348_CR5","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1182\/blood-2008-03-144790","volume":"113","author":"A Quint\u00e1s-Cardama","year":"2009","unstructured":"Quint\u00e1s-Cardama A, Cortes J. Molecular biology of bcr-abl1-positive chronic myeloid leukemia. Blood. 2009;113:1619\u201330.","journal-title":"Blood"},{"key":"348_CR6","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0165-4608(01)00515-5","volume":"132","author":"C Paz-y-Mino","year":"2002","unstructured":"Paz-y-Mino C, Burgos R, Morillo SA, Santos JC, Fiallo BF, Leone PE. BCR-ABL rearrangement frequencies in chronic myeloid leukemia and acute lymphoblastic leukemia in Ecuador South America. Cancer Genet Cytogenet. 2002;132:65\u20137.","journal-title":"Cancer Genet Cytogenet"},{"key":"348_CR7","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1590\/S1415-47572010005000037","volume":"33","author":"EA Osman","year":"2010","unstructured":"Osman EA, Hamad K, Fadl Elmula IM, Ibrahim ME, et al. Frequencies of BCR-ABL1 fusion transcripts among Sudanese chronic myeloid leukaemia patients. Genet Mol Biol. 2010;33:229\u201331.","journal-title":"Genet Mol Biol"},{"key":"348_CR8","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1038\/sj.leu.2401592","volume":"13","author":"JJ Dongen Van","year":"1999","unstructured":"Van Dongen JJ, Macintyre EA, Gabert JA, et al. Standardized RT-PCR analysis of fusion gene transcripts from chromosome aberrations in acute leukaemia for detection of minimal residual disease. Report of the BIOMOED-1 concerted action: investigation of minimal residual disease in acute leukaemia. Leukemia. 1999;13:1901\u201328.","journal-title":"Leukemia"},{"key":"348_CR9","doi-asserted-by":"crossref","first-page":"2410","DOI":"10.1182\/blood.V88.7.2410.bloodjournal8872410","volume":"88","author":"F Pane","year":"1996","unstructured":"Pane F, Frigeri F, Sindona M, Luciano L, Ferrara F, Cimino R, et al. Neutrophilic chronic myeloid leukemia: a distinct disease with a specific molecular marker (BCR-ABL with C3\/A2 junction). Blood. 1996;88:2410\u20134.","journal-title":"Blood"},{"key":"348_CR10","doi-asserted-by":"crossref","first-page":"3343","DOI":"10.1182\/blood.V96.10.3343","volume":"96","author":"MW Deininger","year":"2000","unstructured":"Deininger MW, Goldman JM, Melo JV. The molecular biology of chronic myeloid leukemia. Blood. 2000;96:3343\u201356.","journal-title":"Blood"},{"key":"348_CR11","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1182\/blood.V75.5.1146.1146","volume":"75","author":"L Selleri","year":"1990","unstructured":"Selleri L, von Lindem M, Hermans A, Meijer D, Torelli G, Grosveld G. Chronic myeloid leukemia may be associated with several bcr-ab1 transcripts including the acute lymphoid leukemia-type 7\u00a0kb transcript. Blood. 1990;75:1146.","journal-title":"Blood"},{"key":"348_CR12","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1046\/j.1365-2141.2000.02216.x","volume":"111","author":"SJ Lee","year":"2000","unstructured":"Lee SJ. Chronic myelogenous leukaemia. Br J Haematol. 2000;111:993\u20131009.","journal-title":"Br J Haematol"},{"issue":"98","key":"348_CR13","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1182\/blood.V98.7.2039","volume":"1","author":"JM Goldman","year":"2001","unstructured":"Goldman JM, Druker BJ. Chronic myeloid leukemia: current treatment options. Blood. 2001;1(98):2039\u201342.","journal-title":"Blood"},{"key":"348_CR14","first-page":"803","volume":"4","author":"JA Lemos De","year":"2005","unstructured":"De Lemos JA, de Oliveira CM, Scerni AC, et al. Differential molecular response of the transcripts B2A2 and B3A2 to imatinib mesylate in chronic myeloid leukemia. Genet Mol Res. 2005;4:803\u201311.","journal-title":"Genet Mol Res"},{"key":"348_CR15","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.3324\/haematol.2009.009134","volume":"94","author":"CM Lucas","year":"2009","unstructured":"Lucas CM, Harris RJ, Giannoudis A, et al. Chronic myeloid leukemia patients with the e13a2 BCR-ABL fusion transcript have inferior responses to imatinib compared to patients with the e14a2 transcript. Haematologica. 2009;94:1362\u20137.","journal-title":"Haematologica"},{"key":"348_CR16","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s00277-009-0822-7","volume":"89","author":"P Sharma","year":"2010","unstructured":"Sharma P, Kumar L, Mohanty S, Kochupillai V. Response to Imatinib mesylate in chronic myeloid leukemia patients with variant BCR-ABL fusion transcripts. Ann Hematol. 2010;89:241\u20137.","journal-title":"Ann Hematol"},{"key":"348_CR17","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1002\/ajh.20682","volume":"81","author":"BC Mondal","year":"2006","unstructured":"Mondal BC, Bandyopadhyay A, Majumdar S, et al. Molecular profiling of chronic myeloid leukemia in eastern India. Am J Hematol. 2006;81:845\u20139.","journal-title":"Am J Hematol"},{"key":"348_CR18","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1111\/j.1600-0609.2008.01170.x","volume":"82","author":"R Adler","year":"2009","unstructured":"Adler R, Viehmann S, Kuhlisch E, et al. Correlation of BCR\/ABL transcript variants with patients\u2019 characteristics in childhood chronic myeloid leukaemia. Eur J Haematol. 2009;82:112\u20138.","journal-title":"Eur J Haematol"},{"key":"348_CR19","doi-asserted-by":"crossref","first-page":"3125","DOI":"10.1182\/blood.V78.12.3125.3125","volume":"78","author":"K Inokuchi","year":"1991","unstructured":"Inokuchi K, Inoue T, Tojo A, et al. A possible correlation between the type of bcr-abl hybrid messenger RNA and platelet count in Philadelphia-positive chronic myelogenous leukemia. Blood. 1991;78:3125\u20137.","journal-title":"Blood"},{"key":"348_CR20","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1016\/S0959-8049(00)00128-3","volume":"36","author":"RA Perego","year":"2000","unstructured":"Perego RA, Costantini M, Cornacchini G, et al. The possible influences of B2A2 and B3A2 BCR\/ABL protein structure on thrombopoiesis in chronic myeloid leukaemia. Eur J Cancer. 2000;36:1395\u2013401.","journal-title":"Eur J Cancer"},{"key":"348_CR21","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1002\/1097-0142(19950915)76:6<992::AID-CNCR2820760612>3.0.CO;2-L","volume":"76","author":"CF Verschraegen","year":"1995","unstructured":"Verschraegen CF, Kantarjian HM, Hirsch-Ginsberg C, et al. The breakpoint cluster region site in patients with Philadelphia chromosome-positive chronic myelogenous leukemia. Clinical, laboratory, and prognostic correlations. Cancer. 1995;76:992\u20137.","journal-title":"Cancer"},{"key":"348_CR22","first-page":"1104","volume":"9","author":"C Rozman","year":"1995","unstructured":"Rozman C, Urbano-Ispizua A, Cervantes F, et al. Analysis of the clinical relevance of the breakpoint location within M-BCR and the type of chimeric mRNA in chronic myelogenous leukemia. Leukemia. 1995;9:1104\u20137.","journal-title":"Leukemia"},{"key":"348_CR23","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/0145-2126(92)90039-A","volume":"16","author":"B Opalka","year":"1992","unstructured":"Opalka B, Wandl UB, Kloke O, et al. No correlation between site of breakpoint in the BCR gene and platelet counts in Philadelphia chromosome-positive CML. Leuk Res. 1992;16:937\u20139.","journal-title":"Leuk Res"},{"key":"348_CR24","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1182\/blood.V88.7.2375.bloodjournal8872375","volume":"88","author":"J Melo","year":"1996","unstructured":"Melo J. The diversity of BCR-ABL fusion proteins and their relationship to leukemia phenotype. Blood. 1996;88:2375\u201384.","journal-title":"Blood"},{"issue":"2","key":"348_CR25","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1182\/blood.V70.2.448.448","volume":"70","author":"K Schaefer-Rego","year":"1987","unstructured":"Schaefer-Rego K, Dudek H, Popenoe D, Arlin Z, Mears JG, Bank A, Leibowitz D. CML patients in blast crisis have breakpoints localized to a specific region of the BCR. Blood. 1987;70(2):448\u201355.","journal-title":"Blood"},{"key":"348_CR26","first-page":"642","volume":"2","author":"A Eisenberg","year":"1988","unstructured":"Eisenberg A, Silver R, Soper L, Arlin Z, Coleman M, Bernhardt B, Benn P. The location of breakpoints within the breakpoint cluster region (bcr) of chromosome 22 in chronic myeloid leukemia. Leukemia. 1988;2:642\u20137.","journal-title":"Leukemia"},{"key":"348_CR27","first-page":"731","volume":"5","author":"KI Mills","year":"1991","unstructured":"Mills KI, Birnie GD. Prognostic significance of BCR breakpoint location in M-bcr. Leukemia. 1991;5:731\u20132.","journal-title":"Leukemia"},{"key":"348_CR28","first-page":"723","volume":"6","author":"T Fioretos","year":"1992","unstructured":"Fioretos T, Heim S, Garwicz S, Ludvigsson J, Mitelman F. Molecular analysis of Philadelphia positive childhood chronic myeloid leukemia. Leukemia. 1992;6:723\u20135.","journal-title":"Leukemia"},{"key":"348_CR29","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/j.1365-2141.1993.tb03062.x","volume":"84","author":"A Zaccaria","year":"1993","unstructured":"Zaccaria A, Martinelli G, Buzzi M, Testoni N, Farabegoli P, Zuffa E, Zamagni MD, Russo D, Baccarani M, Ambrosetti A, et al. The type of BCR\/ABL junction does not predict the survival of patients with Ph1-positive chronic myeloid leukaemia. Br J Haematol. 1993;84:265\u20138.","journal-title":"Br J Haematol"},{"key":"348_CR30","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1111\/j.1365-2141.1995.tb08362.x","volume":"89","author":"P Shepherd","year":"1995","unstructured":"Shepherd P, Suffolk R, Halsey J, Allan N. Analysis of molecular breakpoint and m-RNA transcripts in a prospective randomized trial of interferon in chronic myeloid leukaemia: no correlation with clinical features, cytogenetic response, duration of chronic phase, or survival. Br J Haematol. 1995;89:546\u201354.","journal-title":"Br J Haematol"},{"key":"348_CR31","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1046\/j.1365-2141.2000.02042.x","volume":"109","author":"S Branford","year":"2000","unstructured":"Branford S, Rudzki Z, Hughes TP. A novel BCR-ABL transcript (e8a2) with the insertion of an inverted sequence of ABL intron 1b in a patient with Philadelphia-positive chronic myeloid leukaemia. Br J Haematol. 2000;109:635\u20137.","journal-title":"Br J Haematol"},{"key":"348_CR32","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1136\/jcp.2010.078311","volume":"63","author":"A Bennour","year":"2010","unstructured":"Bennour A, Beaufils N, Sennana H, Meddeb B, Saad A, Gabert J. E355G mutation appearing in a patient with e19a2 chronic myeloid leukaemia resistant to imatinib. J Clin Pathol. 2010;63:737\u201340.","journal-title":"J Clin Pathol"},{"key":"348_CR33","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.trsl.2006.07.002","volume":"148","author":"HG Goh","year":"2006","unstructured":"Goh HG, Hwang JY, Kim SH, Lee YH, Kim YL, Kim DW. Comprehensive analysis of BCR-ABL transcript types in Korean CML patients using a newly developed multiplex RT-PCR. Transl Res. 2006;148:249\u201356.","journal-title":"Transl Res"},{"key":"348_CR34","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1111\/j.1365-2141.2004.05100.x","volume":"126","author":"T Ito","year":"2004","unstructured":"Ito T, Tanaka H, Tanaka K, Ito K, Kyo T, Dohy H, et al. Insertion of a genomic fragment of chromosome 19 between BCR intron 19 and ABL intron 1a in a chronic myeloid leukaemia patient with\u2014BCR-ABL (e19a2) transcript. Br J Haematol. 2004;126:750\u20135.","journal-title":"Br J Haematol"},{"issue":"supp 14","key":"348_CR35","first-page":"S86","volume":"22","author":"E Reiter","year":"1998","unstructured":"Reiter E, Greinix HT, Brugger S, Keil F, Rabitsch W, Mannhalter C, et al. Long-term follow-up after allogeneic stem cell transplantation for chronic myelogenous leukemia. Bone Marrow Transp. 1998;22(supp 14):S86\u20138.","journal-title":"Bone Marrow Transp"},{"key":"348_CR36","first-page":"928","volume":"83","author":"C Udomsakdi-Auewarakul","year":"2000","unstructured":"Udomsakdi-Auewarakul C, U-Pratya Y, Boonmoh S, Vatanavicharn S. Detection of molecular variants of BCR-ABL gene in bone marrow and blood of patients with chronic myeloid leukemia by reverse-transcriptase polymerase chain reaction (RT-PCR). J Med Assoc Thai. 2000;83:928\u201335.","journal-title":"J Med Assoc Thai"},{"key":"348_CR37","first-page":"247","volume":"11","author":"M Yaghmaie","year":"2008","unstructured":"Yaghmaie M, Ghaffari SH, Ghavamzadeh A, Alimoghaddam K, Jahani M, Mousavi SA, Irvani M, Bahar B, Bibordi I. Frequency of BCR-ABL Fusion transcripts in Iranian patients with Chronic Myeloid Leukemia. Arch Iran Med. 2008;11:247\u201351.","journal-title":"Arch Iran Med"},{"key":"348_CR38","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1182\/blood.V73.8.2165.2165","volume":"73","author":"MS Lee","year":"1989","unstructured":"Lee MS, LeMaistre A, Kantarjian HM, Talpaz M, Freireich EJ, Trujillo JM, Stass SA. Detection of two alternative bcr\/abl mRNA junctions and minimal residual disease in Philadelphia chromosome positive chronic myelogenous leukemia by polymerase chain reaction. Blood. 1989;73:2165\u201370.","journal-title":"Blood"},{"key":"348_CR39","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1046\/j.1365-2257.2002.00413.x","volume":"24","author":"RM Arana-Trejo","year":"2002","unstructured":"Arana-Trejo RM, Ruiz Sanchez E, Ignacio-Ibarra G, de la Baez Fuente E, Garces O, Gomez Morales E, Arana-Trejo RM, Castro Granados M, Ovilla Martinez R, Rubio-Borja ME, Solis Anaya L, et al. BCR\/ABL p210, p190 and p230 fusion genes in 250 Mexican patients with chronic myeloid leukaemia (CML). Clin Lab Haematol. 2002;24:145\u201350.","journal-title":"Clin Lab Haematol"},{"key":"348_CR40","doi-asserted-by":"crossref","first-page":"504","DOI":"10.2144\/97233rr01","volume":"23","author":"O Henegariu","year":"1997","unstructured":"Henegariu O, Heerema NA, Dlouhy SR, Vance GH, Vogt PH. Multiplex PCR: critical parameters and step-by-step protocol. Biotechniques. 1997;23:504\u201311.","journal-title":"Biotechniques"},{"key":"348_CR41","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1590\/S1415-47572007000400003","volume":"30","author":"D Sastre","year":"2007","unstructured":"Sastre D, Argara\u00f1a C, Heller V, Gallo M, EnFern\u00e1ndez E, Rodr\u00edguez C. An analysis of multiplex-PCR in the detection of BCR-ABL transcripts in hematological disorders. Genet Mol Biol. 2007;30:520\u20133.","journal-title":"Genet Mol Biol"},{"key":"348_CR42","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1002\/gcc.2870010211","volume":"1","author":"C Marcelle","year":"1989","unstructured":"Marcelle C, Gale RP, Prokocimer M, Berrebe A, Merle Beral H, Canani E. Analysis of BCR-ABL mRNA in chronic myelogenous leukemia patients and identification of a new BCR-Related sequence in human DNA. Genes Chromosomes Cancer. 1989;1:172\u20139.","journal-title":"Genes Chromosomes Cancer"},{"key":"348_CR43","first-page":"946","volume":"9","author":"SL Elliott","year":"1995","unstructured":"Elliott SL, Taylor KM, Taylor DL, Rodwell RL, Williams BF, Shuttlewood MM, Wright SJ, Eliadist PE, Bunce IH, Frost TJ, Olsen TE, Firkin F, Timms P. Cytogenetic response to alpha-interferon is predicted in early chronic phase chronic myeloid leukemia by M-bcr breakpoint location. Leukemia. 1995;9:946.","journal-title":"Leukemia"},{"key":"348_CR44","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/j.1365-2141.1990.tb02534.x","volume":"74","author":"J Jaubert","year":"1990","unstructured":"Jaubert J, Martiat P, Dowding C, Ifrah N, Goldman J. The position of the M-BCR breakpoint does not predict the duration of chronic phase or survival in chronic myeloid leukaemia. Br J Haematol. 1990;74:30\u20135.","journal-title":"Br J Haematol"},{"key":"348_CR45","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1182\/blood.V75.10.2035.2035","volume":"75","author":"SW Morris","year":"1990","unstructured":"Morris SW, Daniel L, Ahmed CM, Elias A, Lebowitz P. Relationship of bcr breakpoint to chronic phase duration, survival, and blast crisis lineage in chronic myelogenous leukemia patients presenting in early chronic phase. Blood. 1990;75:2035\u201341.","journal-title":"Blood"},{"key":"348_CR46","first-page":"666","volume":"87","author":"M Mart\u00ednez-Mancilla","year":"2002","unstructured":"Mart\u00ednez-Mancilla M, Guti\u00e9rrez M, de la Rosa GZ, Garc\u00eda-Carranc\u00e1 A, Gariglio P, Miranda E. Younger age and shorter chronic phase in b2a2-positive chronic myeloid leukemia adults with high white blood cell count at diagnosis. Haematologica. 2002;87:666\u20138.","journal-title":"Haematologica"},{"key":"348_CR47","first-page":"1241","volume":"10","author":"F Cervantes","year":"1996","unstructured":"Cervantes F, Colomer D, Vives-Corrons JL, Rozman C, Montserrat E. Chronic myeloid leukemia of thrombocythemic onset: a CML subtype with distinct hematological and molecular features? Leukemia. 1996;10:1241\u20133.","journal-title":"Leukemia"},{"key":"348_CR48","doi-asserted-by":"crossref","first-page":"2768","DOI":"10.1182\/blood.V90.7.2768","volume":"90","author":"D Blickstein","year":"1997","unstructured":"Blickstein D, Aviram A, Luboshitz J, Prokocimer M, Stark P, Bairey O, Sulkes J, Shaklai M. BCR-ABL transcripts in bone marrow aspirates of Philadelphia-negative essential thrombocytopenia patients: clinical presentation. Blood. 1997;90:2768\u201371.","journal-title":"Blood"},{"key":"348_CR49","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1002\/cncr.10490","volume":"94","author":"S Verstovsek","year":"2002","unstructured":"Verstovsek S, Lin H, Kantarjian H, Saglio G, De Micheli D, Pane F, Garcia-Manero G, Intrieri M, Rotoli B, Salvatore F, Guo JQ, Talpaz M, Specchia G, Pizzolo G, Liberati AM, Cortes J, Quackenbush RC, Arlinghaus RB. Neutrophilic-chronic myeloid leukemia: low levels of p230 BCR\/ABL mRNA and undetectable BCR\/ABL protein may predict an indolent course. Cancer. 2002;94:2416\u201325.","journal-title":"Cancer"}],"container-title":["Medical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-012-0348-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12032-012-0348-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-012-0348-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,19]],"date-time":"2020-07-19T11:37:46Z","timestamp":1595158666000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12032-012-0348-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12,27]]},"references-count":49,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,3]]}},"alternative-id":["348"],"URL":"https:\/\/doi.org\/10.1007\/s12032-012-0348-z","relation":{},"ISSN":["1357-0560","1559-131X"],"issn-type":[{"value":"1357-0560","type":"print"},{"value":"1559-131X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,12,27]]},"article-number":"348"}}